Industry: Chemical & Material
Published Date: 2024-11-26
Pages: 129 Pages
Report ld: 3384403
Request Sample
Customized Report
Proparacaine API Market Size(US$)

CAGR 2024-2030
4.3%
Market Size,2030
USD 321
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Proparacaine API was estimated to be worth US$ 239 million in 2023 and is forecast to a readjusted size of US$ 321 million by 2030 with a CAGR of 4.3% during the forecast period 2024-2030.
Proparacaine is a local anesthetic used primarily in ophthalmology. Proparacaine temporarily paralyzes the surface of the eye by blocking nerve signal transmission, making it useful for diagnostic and minor surgical procedures such as intraocular pressure measurement or foreign body removal.
North American market for Proparacaine API was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Proparacaine API was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Proparacaine API was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Proparacaine API include Xi'an Tian Guangyuan Biotech, Siegfried, Xianqiang Pharmaceutical, Lifeon, MITACHIEVE, WUHAN XINXINJIALI BIOTECHNOLOGY, Angle Bio Pharma, Fengchen Group, Conscientia Industrial, Pharmaffiliates, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Proparacaine API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Proparacaine API by region & country, by Type, and by Application.
The Proparacaine API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Proparacaine API.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Proparacaine API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Proparacaine API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Proparacaine API in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Proparacaine API Product Introduction
1.2 Global Proparacaine API Market Size Forecast
1.2.1 Global Proparacaine API Sales Value (2019-2030)
1.2.2 Global Proparacaine API Sales Volume (2019-2030)
1.2.3 Global Proparacaine API Sales Price (2019-2030)
1.3 Proparacaine API Market Trends & Drivers
1.3.1 Proparacaine API Industry Trends
1.3.2 Proparacaine API Market Drivers & Opportunity
1.3.3 Proparacaine API Market Challenges
1.3.4 Proparacaine API Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Proparacaine API Players Revenue Ranking (2023)
2.2 Global Proparacaine API Revenue by Company (2019-2024)
2.3 Global Proparacaine API Players Sales Volume Ranking (2023)
2.4 Global Proparacaine API Sales Volume by Company Players (2019-2024)
2.5 Global Proparacaine API Average Price by Company (2019-2024)
2.6 Key Manufacturers Proparacaine API Manufacturing Base and Headquarters
2.7 Key Manufacturers Proparacaine API Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Proparacaine API
2.9 Proparacaine API Market Competitive Analysis
2.9.1 Proparacaine API Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Proparacaine API Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Proparacaine API as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Purity Above 99%
3.1.2 Purity Below 99%
3.2 Global Proparacaine API Sales Value by Type
3.2.1 Global Proparacaine API Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Proparacaine API Sales Value, by Type (2019-2030)
3.2.3 Global Proparacaine API Sales Value, by Type (%) (2019-2030)
3.3 Global Proparacaine API Sales Volume by Type
3.3.1 Global Proparacaine API Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Proparacaine API Sales Volume, by Type (2019-2030)
3.3.3 Global Proparacaine API Sales Volume, by Type (%) (2019-2030)
3.4 Global Proparacaine API Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Ophthalmic Procedures
4.1.2 Diagnostic Use
4.2 Global Proparacaine API Sales Value by Application
4.2.1 Global Proparacaine API Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Proparacaine API Sales Value, by Application (2019-2030)
4.2.3 Global Proparacaine API Sales Value, by Application (%) (2019-2030)
4.3 Global Proparacaine API Sales Volume by Application
4.3.1 Global Proparacaine API Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Proparacaine API Sales Volume, by Application (2019-2030)
4.3.3 Global Proparacaine API Sales Volume, by Application (%) (2019-2030)
4.4 Global Proparacaine API Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Proparacaine API Sales Value by Region
5.1.1 Global Proparacaine API Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Proparacaine API Sales Value by Region (2019-2024)
5.1.3 Global Proparacaine API Sales Value by Region (2025-2030)
5.1.4 Global Proparacaine API Sales Value by Region (%), (2019-2030)
5.2 Global Proparacaine API Sales Volume by Region
5.2.1 Global Proparacaine API Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Proparacaine API Sales Volume by Region (2019-2024)
5.2.3 Global Proparacaine API Sales Volume by Region (2025-2030)
5.2.4 Global Proparacaine API Sales Volume by Region (%), (2019-2030)
5.3 Global Proparacaine API Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Proparacaine API Sales Value, 2019-2030
5.4.2 North America Proparacaine API Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Proparacaine API Sales Value, 2019-2030
5.5.2 Europe Proparacaine API Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Proparacaine API Sales Value, 2019-2030
5.6.2 Asia Pacific Proparacaine API Sales Value by Region (%), 2023 VS 2030
5.7 South America
5.7.1 South America Proparacaine API Sales Value, 2019-2030
5.7.2 South America Proparacaine API Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Proparacaine API Sales Value, 2019-2030
5.8.2 Middle East & Africa Proparacaine API Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Proparacaine API Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Proparacaine API Sales Value
6.2.1 Key Countries/Regions Proparacaine API Sales Value, 2019-2030
6.2.2 Key Countries/Regions Proparacaine API Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Proparacaine API Sales Value, 2019-2030
6.3.2 United States Proparacaine API Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Proparacaine API Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Proparacaine API Sales Value, 2019-2030
6.4.2 Europe Proparacaine API Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Proparacaine API Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Proparacaine API Sales Value, 2019-2030
6.5.2 China Proparacaine API Sales Value by Type (%), 2023 VS 2030
6.5.3 China Proparacaine API Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Proparacaine API Sales Value, 2019-2030
6.6.2 Japan Proparacaine API Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Proparacaine API Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Proparacaine API Sales Value, 2019-2030
6.7.2 South Korea Proparacaine API Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Proparacaine API Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Proparacaine API Sales Value, 2019-2030
6.8.2 Southeast Asia Proparacaine API Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Proparacaine API Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Proparacaine API Sales Value, 2019-2030
6.9.2 India Proparacaine API Sales Value by Type (%), 2023 VS 2030
6.9.3 India Proparacaine API Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Xi'an Tian Guangyuan Biotech
7.1.1 Xi'an Tian Guangyuan Biotech Company Information
7.1.2 Xi'an Tian Guangyuan Biotech Introduction and Business Overview
7.1.3 Xi'an Tian Guangyuan Biotech Proparacaine API Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Xi'an Tian Guangyuan Biotech Proparacaine API Product Offerings
7.1.5 Xi'an Tian Guangyuan Biotech Recent Development
7.2 Siegfried
7.2.1 Siegfried Company Information
7.2.2 Siegfried Introduction and Business Overview
7.2.3 Siegfried Proparacaine API Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Siegfried Proparacaine API Product Offerings
7.2.5 Siegfried Recent Development
7.3 Xianqiang Pharmaceutical
7.3.1 Xianqiang Pharmaceutical Company Information
7.3.2 Xianqiang Pharmaceutical Introduction and Business Overview
7.3.3 Xianqiang Pharmaceutical Proparacaine API Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Xianqiang Pharmaceutical Proparacaine API Product Offerings
7.3.5 Xianqiang Pharmaceutical Recent Development
7.4 Lifeon
7.4.1 Lifeon Company Information
7.4.2 Lifeon Introduction and Business Overview
7.4.3 Lifeon Proparacaine API Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Lifeon Proparacaine API Product Offerings
7.4.5 Lifeon Recent Development
7.5 MITACHIEVE
7.5.1 MITACHIEVE Company Information
7.5.2 MITACHIEVE Introduction and Business Overview
7.5.3 MITACHIEVE Proparacaine API Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 MITACHIEVE Proparacaine API Product Offerings
7.5.5 MITACHIEVE Recent Development
7.6 WUHAN XINXINJIALI BIOTECHNOLOGY
7.6.1 WUHAN XINXINJIALI BIOTECHNOLOGY Company Information
7.6.2 WUHAN XINXINJIALI BIOTECHNOLOGY Introduction and Business Overview
7.6.3 WUHAN XINXINJIALI BIOTECHNOLOGY Proparacaine API Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 WUHAN XINXINJIALI BIOTECHNOLOGY Proparacaine API Product Offerings
7.6.5 WUHAN XINXINJIALI BIOTECHNOLOGY Recent Development
7.7 Angle Bio Pharma
7.7.1 Angle Bio Pharma Company Information
7.7.2 Angle Bio Pharma Introduction and Business Overview
7.7.3 Angle Bio Pharma Proparacaine API Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Angle Bio Pharma Proparacaine API Product Offerings
7.7.5 Angle Bio Pharma Recent Development
7.8 Fengchen Group
7.8.1 Fengchen Group Company Information
7.8.2 Fengchen Group Introduction and Business Overview
7.8.3 Fengchen Group Proparacaine API Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 Fengchen Group Proparacaine API Product Offerings
7.8.5 Fengchen Group Recent Development
7.9 Conscientia Industrial
7.9.1 Conscientia Industrial Company Information
7.9.2 Conscientia Industrial Introduction and Business Overview
7.9.3 Conscientia Industrial Proparacaine API Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 Conscientia Industrial Proparacaine API Product Offerings
7.9.5 Conscientia Industrial Recent Development
7.10 Pharmaffiliates
7.10.1 Pharmaffiliates Company Information
7.10.2 Pharmaffiliates Introduction and Business Overview
7.10.3 Pharmaffiliates Proparacaine API Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 Pharmaffiliates Proparacaine API Product Offerings
7.10.5 Pharmaffiliates Recent Development
7.11 Enomark
7.11.1 Enomark Company Information
7.11.2 Enomark Introduction and Business Overview
7.11.3 Enomark Proparacaine API Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 Enomark Proparacaine API Product Offerings
7.11.5 Enomark Recent Development
8 Industry Chain Analysis
8.1 Proparacaine API Industrial Chain
8.2 Proparacaine API Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Proparacaine API Sales Model
8.5.2 Sales Channel
8.5.3 Proparacaine API Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Proparacaine API market is projected to grow from US$ 259 million in 2025 to US$ 346 million by 2032, at a CAGR of 4.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-25
Pages: 163
USD 4900.00
(Single User License)
The global Proparacaine API market size was US$ 259 million in 2025 and is forecast to reach a readjusted size of US$ 346 million by 2032 with a CAGR of 4.3% during the forecast period 2026-2032.
Published Date: 2026-03-25
Pages: 96
USD 4250.00
(Single User License)
The global Proparacaine API market was valued at US$ 259 million in 2025 and is anticipated to reach US$ 346 million by 2032, at a CAGR of 4.3% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 142
USD 2900.00
(Single User License)
The global market for Proparacaine API was estimated to be worth US$ 259 million in 2025 and is projected to reach US$ 346 million, growing at a CAGR of 4.3% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 120
USD 3950.00
(Single User License)
The global Proparacaine API market is projected to grow from US$ 249 million in 2024 to US$ 333 million by 2031, at a CAGR of 4.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-01
Pages: 161
USD 4900.00
(Single User License)
The global Proparacaine API market size was US$ 249 million in 2024 and is forecast to a readjusted size of US$ 333 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 99
USD 4250.00
(Single User License)
The global market for Proparacaine API was estimated to be worth US$ 249 million in 2024 and is forecast to a readjusted size of US$ 333 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 116
USD 3950.00
(Single User License)
The global market for Proparacaine API was valued at US$ 249 million in the year 2024 and is projected to reach a revised size of US$ 333 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Published Date: 2025-03-10
Pages: 96
USD 2900.00
(Single User License)
The global Proparacaine API revenue was US$ 239 million in 2023 and is forecast to a readjusted size of US$ 321 million by 2030 with a CAGR of 4.3% during the review period (2024-2030).
Published Date: 2024-11-26
Pages: 125
USD 4350.00
(Single User License)
Valued at US$ 249 million in 2024, the global Proparacaine API market is forecast to reach US$ 321 million by 2030, at a CAGR of 4.3% during the forecast period.
Published Date: 2024-11-26
Pages: 164
USD 4900.00
(Single User License)
The global Proparacaine API market is projected to grow from US$ 259 million in 2025 to US$ 346 million by 2032, at a CAGR of 4.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-25
Pages: 163
The global Proparacaine API market size was US$ 259 million in 2025 and is forecast to reach a readjusted size of US$ 346 million by 2032 with a CAGR of 4.3% during the forecast period 2026-2032.
Published: 2026-03-25
Pages: 96
The global Proparacaine API market was valued at US$ 259 million in 2025 and is anticipated to reach US$ 346 million by 2032, at a CAGR of 4.3% from 2026 to 2032.
Published: 2026-01-08
Pages: 142
The global market for Proparacaine API was estimated to be worth US$ 259 million in 2025 and is projected to reach US$ 346 million, growing at a CAGR of 4.3% from 2026 to 2032.
Published: 2026-01-08
Pages: 120
The global Proparacaine API market is projected to grow from US$ 249 million in 2024 to US$ 333 million by 2031, at a CAGR of 4.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-01
Pages: 161
The global Proparacaine API market size was US$ 249 million in 2024 and is forecast to a readjusted size of US$ 333 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 99
The global market for Proparacaine API was estimated to be worth US$ 249 million in 2024 and is forecast to a readjusted size of US$ 333 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 116
The global market for Proparacaine API was valued at US$ 249 million in the year 2024 and is projected to reach a revised size of US$ 333 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Published: 2025-03-10
Pages: 96
The global Proparacaine API revenue was US$ 239 million in 2023 and is forecast to a readjusted size of US$ 321 million by 2030 with a CAGR of 4.3% during the review period (2024-2030).
Published: 2024-11-26
Pages: 125
Valued at US$ 249 million in 2024, the global Proparacaine API market is forecast to reach US$ 321 million by 2030, at a CAGR of 4.3% during the forecast period.
Published: 2024-11-26
Pages: 164
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now